Sunshine Biopharma Inc (SBFM) — Cash Flow-to-Debt Ratio
Sunshine Biopharma Inc (SBFM) has a Cash Flow-to-Debt Ratio of -0.23x as of March 2026, meaning its operating cash flow of $-1.62 Million could theoretically repay 0% of its total liabilities ($7.04 Million) in one year. See Sunshine Biopharma Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sunshine Biopharma Inc Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Sunshine Biopharma Inc across 19 annual periods. Also explore Sunshine Biopharma Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sunshine Biopharma Inc (2007–2025)
Year-by-year debt coverage analysis for Sunshine Biopharma Inc. For market capitalisation and broader financial context, see Sunshine Biopharma Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.76x | $-5.33 Million | $7.04 Million | ▲ +57.3% |
| 2024 | -1.78x | $-12.53 Million | $7.06 Million | ▼ -24.2% |
| 2023 | -1.43x | $-8.78 Million | $6.14 Million | ▼ -115.6% |
| 2022 | -0.66x | $-5.25 Million | $7.92 Million | ▲ +27.8% |
| 2021 | -0.92x | $-1.83 Million | $1.99 Million | ▼ -179.5% |
| 2020 | -0.33x | $-657.30K | $2.00 Million | ▲ +44.8% |
| 2019 | -0.59x | $-495.80K | $833.53K | ▼ -39.5% |
| 2018 | -0.43x | $-512.81K | $1.20 Million | ▲ +34.8% |
| 2017 | -0.65x | $-543.52K | $830.85K | ▲ +42.9% |
| 2016 | -1.15x | $-314.18K | $274.10K | ▼ -67.8% |
| 2015 | -0.68x | $-867.64K | $1.27 Million | ▲ +32.7% |
| 2014 | -1.01x | $-538.60K | $531.00K | ▲ +93.0% |
| 2013 | -14.49x | $-564.40K | $38.95K | ▼ -137.3% |
| 2012 | -6.11x | $-393.05K | $64.37K | ▲ +92.9% |
| 2011 | -86.58x | $-297.30K | $3.43K | ▼ -183.4% |
| 2010 | -30.54x | $-348.32K | $11.40K | ▼ -4175.9% |
| 2009 | -0.71x | $-10.22K | $14.31K | ▲ +29.5% |
| 2008 | -1.01x | $-23.03K | $22.74K | ▲ +51.3% |
| 2007 | -2.08x | $-3.12K | $1.50K | — |